TCG Crossover Management »

Soleno Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Soleno Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2925M26M27M28M549.999k549.9995k550k550.0005k550.001k
Value ($)Share countHistorical SLNO position of TCG Crossover Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $25M 550k 44.95
2024-09-30 $28M 550k 50.49

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Xencor Comm (XNCR)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Ocular Therapeutix Comm (OCUL)
Upstream Bio Comm
Abivax Sa American Depositary Shares Adrs (ABVX)
Savara Comm (SVRA)
Tango Therapeutics Comm (TNGX)
Dianthus Therapeutics Comm (DNTH)
Disc Medicine Comm (IRON)
Mineralys Therapeutics Comm (MLYS)
Tourmaline Bio Comm (TRML)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics